Nonoperative treatment of unicompartmental arthritis of the knee.
Treatment of the knee with unicompartmental osteoarthritis remains a challenging clinical problem. Despite pharmacologic advances and surgical innovations, the ideal strategy for the patient who has single-compartment degenerative disease can be complicated. The understanding and management of this problem are further confounded by the fact that so much of the data are unreliable. Given these constraints, this article outlines the current alternatives available in nonoperatively managing the symptomatic unicompartmental arthritic knee.
Hanypsiak
Bryan T
BT
Orthopaedic Associates of Long Island, 6 Technology Drive, Suite 100, East Setauket, New York 11733, USA. bhanypsiak@optonline.net
Shaffer
Benjamin S
BS
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000287:Administration, Topical; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001182:Arthroscopy; D002807:Chondroitin / Q000627:therapeutic use; D003348:Cortisone / Q000008:administration & dosage / Q000627:therapeutic use; D019587:Dietary Supplements; D005944:Glucosamine / Q000627:therapeutic use; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D007270:Injections, Intra-Articular; D008019:Life Style; D009989:Orthotic Devices; D020370:Osteoarthritis, Knee / Q000628:therapy*
D000276:Adjuvants, Immunologic; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D006820:Hyaluronic Acid; D002807:Chondroitin; D005944:Glucosamine; D003348:Cortisone